Skip to main content
PLOS One logoLink to PLOS One
. 2023 Jul 17;18(7):e0288465. doi: 10.1371/journal.pone.0288465

Availability and use of personal protective equipment in low- and middle-income countries during the COVID-19 pandemic

Salomé Henriette Paulette Drouard 1,*, Tashrik Ahmed 2, Pablo Amor Fernandez 1, Prativa Baral 2, Michael Peters 2, Peter Hansen 2, Tawab Hashemi 2, Isidore Sieleunou 2, Munirat Iyabode Ogunlayi 2, Alain-Desire Karibwami 2, Julie Ruel Bergeron 2, Edwin Eduardo Montufar Velarde 3, Mohamed Lamine Yansane 4, Chea Sanford Wesseh 5, Charles Mwansambo 6, Charles Nzelu 7, Helal Uddin 8, Mahamadi Tassembedo 9, Gil Shapira 1
Editor: Allen Prabhaker Ugargol10
PMCID: PMC10351736  PMID: 37459298

Abstract

Background

Availability and appropriate use of personal protective equipment (PPE) is of particular importance in Low and Middle-Income countries (LMICs) where disease outbreaks other than COVID-19 are frequent and health workers are scarce. This study assesses the availability of necessary PPE items during the COVID-19 pandemic at health facilities in seven LMICs.

Methods

Data were collected using a rapid-cycle survey among 1554 health facilities in seven LMICs via phone-based surveys between August 2020 and December 2021. We gathered data on the availability of World Health Organization (WHO)-recommended PPE items and the use of items when examining patients suspected to be infected with COVID-19. We further investigated the implementation of service adaptation measures in a severe shortage of PPE.

Results

There were major deficiencies in PPE availability at health facilities. Almost 3 out of 10 health facilities reported a stock-out of medical masks on the survey day. Forty-six percent of facilities did not have respirator masks, and 16% did not have any gloves. We show that only 43% of health facilities had sufficient PPE to comply with WHO guidelines. Even when all items were available, healthcare workers treating COVID-19 suspected patients were reported to wear all the recommended equipment in only 61% of health facilities. We did not find a statistically significant difference in implementing service adaptation measures between facilities experiencing a severe shortage or not.

Conclusion

After more than a year into the COVID-19 pandemic, the overall availability of PPE remained low in our sample of low and middle-income countries. Although essential, the availability of PPE did not guarantee the proper use of the equipment. The lack of PPE availability and improper use of available PPE enable preventable COVID-19 transmission in health facilities, leading to greater morbidity and mortality and risking the continuity of service delivery by healthcare workers.

Introduction

Ensuring the availability and use of personal protective equipment (PPE) among healthcare workers (HCWs) is essential for reducing the transmission of infectious diseases within health facilities. The 2013–2016 West Africa Ebola epidemic demonstrated that HCW mortality and morbidity weakens the capacity for crisis response and created long-term challenges in providing primary health services [1]. The use of PPE is an important strategy to protect HCW and patients from the spread of pathogens and cross-contamination [2, 3]. During the COVID-19 pandemic, the prevalence of infection is disproportionately higher among HCW than in the general population: HCW represented less than 3% of the global population but in 2020 accounted for more than 14% of the infections [3]. Though PPE supply chains had stabilized, insufficient PPE availability was a major source of service disruption in 26% of countries between January 2021 and March 2021 [4]. Improving PPE availability and use is a cost-effective and straightforward way to protect the health workforce during epidemics [5].

In March 2020, World Health Organization guidance defined appropriate PPE for interacting with a suspected COVID-19 patient as the use of: "a medical mask […] [and] eye protection (goggles) or facial protection (face shield) to avoid contamination of mucous membranes; […] [and] a clean, non-sterile, long-sleeved gown; […] [and] gloves" [6]. Additional airborne precautions must be taken by wearing a respirator (e.g., N95 or FFP2) for aerosol-generating procedures such as intubation or noninvasive ventilation.

In low and middle-income countries (LMICs), shortages and non-compliance to guidelines on PPE use pre-dated the COVID-19 pandemic [7]. For example, severe shortages of face masks were documented in the Service Provisions Assessments (SPAs) in the Democratic Republic of Congo (2018), Nepal (2015), and Tanzania (2015) [8]. Moreover, a systematic review on PPE use for respiratory infections from 2019 emphasized the low level of compliance with PPE use among HCWs in Pakistan [9]. Despite efforts to strengthen PPE supply during the pandemic, initial evidence suggested that global shortages had persisted. For instance, data from a facility phone survey in Kenya in July 2021 showed that only 15% had access to the complete PPE set available at the health facility [10].

In response to global stock-outs of PPE and to limit the spread of the virus among HCW, WHO recommended adapting service provision when severe shortages were experienced by limiting face-to-face interaction between HCWs and patients [11]. Extending prescriptions, encouraging self-care, providing all care in a single visit, and switching to a digital platform are relevant to service adaptions to respond to a severe PPE shortage as recommended by WHO.

The lack of equipment, combined with low capacities to adapt service delivery, increases the risk of HCWs infection and limits the response to epidemics [12]. To our knowledge, the implementation of infection prevention and control (IPC) measures and service adaptation in LMICs in response to COVID-19 have not yet been measured. Documenting the implementation of IPC measures and service adaptation is essential to highlight strategies to ensure the safety of HCWs and the continuity of essential health services during prolonged and future PPE shortages.

There is limited recent evidence in LMICs on PPE availability and use since the early pandemic or on the implementation of service adaptation in response to experiencing a severe shortage. In this paper, we described the availability of COVID-19 appropriate PPE in seven LMICs during the pandemic and the use of these barriers by HCWs when providing care to suspected and confirmed cases of COVID-19. In cases of severe PPE shortage, we further assessed the implementation of service adaptation measures.

Methods

Overview and sample selection

To monitor the continuity of essential health services during the pandemic, the Global Financing Facility for Women, Children, and Adolescents (GFF) supported partner countries in implementing rapid-cycle phone-based health facility surveys. In this context, implementation of facility phone surveys was offered to all partner countries. The seven countries covered by this study are the ones that opted to implement the phone survey and for which at least one round of data was completed by August 2021. These surveys assessed the effect of the pandemic on the ability to deliver essential health services and document adaptations to service delivery modalities. Surveys were conducted in Bangladesh, Burkina Faso, Guatemala, Guinea, Liberia, Malawi, and Nigeria between May 2021 and August 2021. All samples, besides Nigeria, are nationally representative and stratified by administrative units. From a master facility list provided by the Ministry of Health, Health facilities were randomly selected within each administrative unit, and the number of health facilities picked reflects the weight of the stratum at the national level. The Nigeria sample was stratified by the COVID burden at the state level as of August 2020, S1 Table details the number of rounds and reference periods for each country. Standard questionnaires were adapted to each country’s context and priorities. The specific sampling strategy varied by country and is presented in S2 Table.

Data collection

Survey respondents generally included facility officer in-charges, but in some cases other respondents, like facility administrators, were better suited to answer modules within the survey. Three attempts were made to reach each facility, and interview times were scheduled in advance to minimize burden on the respondents. In case of non-response, a replacement facility of the same facility level in the same province was randomly selected from the list of eligible health facilities when possible. More details on the response rate are available in S3 Table. All the health facility representatives we managed to reach accepted to take part in the survey.

Analysis

To assess availability, we computed the frequencies of health facilities reporting the availability of any PPE within health facilities, the availability of PPE to all healthcare workers, and the availability of a complete PPE set as defined by WHO [6]. We examined the availability of the following PPE: gowns, goggles, face shields, gloves, medical masks, and respirators (N95 of FFP2). Availability is described by 1) the presence of at least one of each type of PPE within the health facility and 2) the availability of each PPE to all health workers. As defined by March 2020 WHO guidance [6], we measured the frequency of the availability of a complete PPE set as composed of a gown, a pair of gloves, face or eye protection, and a mask (medical or respirator).

Our study investigated the use of PPE when examining COVID-19 suspected patients. Use of PPE was assessed by a self-report of the PPE health workers routinely used during a consultation with a suspected or confirmed COVID-19 case. This is benchmarked against the set of PPE recommended by WHO guidance; i.e., HCWs wearing a protective gown, eye or facial protection (goggles or face shields), gloves, and a mask (medical masks or respirators).

Finally, we considered health facility service adaptation in the event of a severe shortage of PPE barriers [11]. There is not a unique definition of severe PPE shortage. We chose to define health facilities without any available gloves or masks (medical masks and respirators) as experiencing a severe shortage. Gloves and masks are the minimum set of required PPE to maintain spatial separation for basic contact and droplet precautions for healthcare workers caring for suspected COVID-19 patients. Gloves and masks are also more difficult to replace with an alternative or homemade PPE. In facilities with severe shortages, adaptations to service delivery to limit in-person consultations according to WHO guidance were assessed by four possible service adaptation measures: extending prescriptions, encouraging self-care, providing all care in a single visit, and switching to a digital platform. We also investigated the adoption of different Infection Prevention Control (IPC) measures health facilities took during a severe shortage of PPE. We considered different IPC measures to respond to COVID-19, such as regular cleaning of surfaces, available hand-washing stations and a dedicated entry for staff members, screening patients for COVID-19, implementing a triage system with COVID-19 dedicated areas, and maintaining social distancing. To understand if service adaption reflects PPE severe shortage, we analyzed the likelihood of health facilities adopting each service adaptation and IPC measure when experiencing a stock out. The likelihood of adopting each measure when experiencing a severe shortage was assessed by X2 tests.

Ethical approval

The study was requested, reviewed, and approved by a director-level official in each Ministry of Health and was exempted from human subjects research as public health practice in every country except Burkina Faso. In Burkina Faso, ethical approval was received from the ethics committee of the local author’s institute. Survey participation was voluntary and verbal consent was received from all respondents.

Results

Sample characteristics

The total sample included 1554 health facilities from seven countries (Table 1). Seventy-two percent of the health facilities were rural, 7% were peri-urban, and 21% urban. Health facilities were either hospitals, health centers, or health posts defined by the country’s health management system. Forty-nine percent of the health facilities were health centers. Eighty-six percent were from the public sector.

Table 1. Facility characteristics.

  Bangladesh (n = 291) Burkina Faso (n = 159) Guatemala (n = 239) Guinea (n = 156) Liberia (n = 116) Malawi (n = 192) Nigeria (n = 401) Total (n = 1554)
Location                
Urban (%) 20 10 24 29 21 7 27 21
Peri-urban (%) 17 2 0 0 0 5 10 7
Rural (%) 63 88 75 71 79 88 63 72
Facility type                
Hospital (%) 33 3 4 3 12 8 10 12
Health center (%) 33 97 15 94 10 84 31 47
Health Post/ Clinic (%) 34 0 81 3 78 8 55 40
Other (%)  0 0 0 0 0 0 3 1
Managing authority                
Government, public (%) 100 100 100 100 100 72 60 86
Private, for profit (%) 0 0 0 0 0 1 40 11
Private, nonprofit (%) 0 0 0 0 0 27 0 3

Availability assessment

There were major deficiencies in PPE availability at health facilities (Table 2), as well as substantial variation across items, countries, and facility types. Shortages existed for all PPE items. Table 2 shows that only 43% of health facilities had sufficient PPE available to comply with WHO guidelines on the day of the survey. Almost 3 out of 10 health facilities reported a stock-out of medical masks on the day of the survey. Forty-six percent of facilities did not have respirator masks, and 16% did not have any gloves. On average, health facilities in our sample had 4.1 types of PPE available out of the six recommended during the COVID-19 pandemic. Facilities in Bangladesh and Guinea had the lowest availability of all items, with an average of 2.7 items out of six. At the other end of the spectrum, Liberian facilities, on average, reported 5.3 items available. In all countries, hospitals had a higher average availability of items in comparison to the primary-level facilities. The availability of PPE was near 100% for hospitals in Malawi, Liberia, Guatemala, and Burkina Faso. In countries where several rounds of data collection took place, we did not observe substantial changes in the availability of supplies between February 2021 and August 2021 (S1 Table), with only a one percentage point average change between the first and last round.

Table 2. Availability at the health facility level for each piece of PPE by country by facility type.

Country Facility type n # items sd Gown Gloves Goggles Face shields N95/FFP2 Medical masks Complete PPE set
Bangladesh Total 291 2.7 2.25 51% 55% 42% 38% 25% 63% 28%
Hospitals 96 4.9 1.36 90% 95% 82% 73% 53% 94% 67%
Health centers 96 1.9 2.06 33% 43% 28% 26% 14% 47% 16%
Health posts 99 1.5 1.56 31% 28% 16% 17% 8% 49% 3%
Burkina Faso Total 159 4.7 1.07 94% 97% 79% 91% 59% 55% 62%
Hospitals 4 5.8 0.50 100% 100% 100% 100% 100% 75% 100%
Health centers 155 4.7 1.07 94% 97% 79% 90% 58% 54% 61%
Guatemala Total 239 4.9 1.34 79% 93% 82% 79% 72% 89% 60%
Hospitals 10 5.9 0.32 100% 100% 100% 100% 90% 100% 100%
Health centers 35 5.5 1.04 89% 97% 91% 91% 86% 97% 77%
Health posts 194 4.8 1.38 77% 92% 80% 76% 68% 87% 55%
Guinea Total 156 2.7 1.67 64% 63% 47% 52% 10% 31% 8%
Hospitals 5 1.8 2.05 40% 20% 40% 40% 0% 40% 20%
Health centers 146 2.7 1.66 63% 65% 45% 52% 10% 30% 8%
Health posts 5 1.2 1.79 40% 20% 40% 20% 0% 0% 0%
Liberia Total 116 5.3 1.05 97% 97% 85% 91% 80% 78% 72%
Hospitals 14 5.6 0.84 100% 86% 93% 100% 93% 93% 86%
Health centers 11 5.4 0.81 100% 100% 82% 100% 82% 73% 64%
Health posts 91 5.2 1.09 96% 98% 85% 89% 78% 77% 71%
Malawi Total 192 4.8 1.48 68% 95% 73% 88% 74% 97% 53%
Hospitals 15 5.9 0.35 93% 93% 100% 100% 100% 100% 87%
Health centers 161 4.7 1.53 63% 94% 68% 87% 70% 96% 47%
Health posts 16 5.8 0.58 94% 100% 100% 94% 88% 100% 88%
Nigeria Total 401 4.0 1.76 70% 95% 45% 50% 61% 80% 36%
Hospitals 42 4.7 1.27 93% 98% 50% 64% 76% 90% 48%
Health centers 126 4.0 1.62 75% 95% 45% 48% 60% 73% 33%
Health posts 220 3.9 1.89 64% 94% 44% 49% 56% 85% 36%
Other 13 3.8 1.59 62% 100% 38% 38% 100% 38% 23%
Sample 1554 4.1 1.9 72% 84% 60% 65% 54% 73% 43%

Even in countries where PPE was generally available at the facility level, there were often insufficient quantities to protect all health workers, as shown in Fig 1. For example, although 78% of health facilities reported having masks in Liberia, only 38% of facilities had enough masks for all HCW. For medical masks, Guinea had the lowest availability for all HCW at 26%. For respiratory masks, the average availability across all countries was 43% and was lowest in Bangladesh at 7%.

Fig 1. Availability at the HF level and to all HCWs for each piece of PPE by country.

Fig 1

The gap in availability is shown by the distance between the availability of the PPE barrier at the health facility and the availability to all HCWs points.

Compliance with WHO guidelines on PPE with COVID-19 suspected cases

Regarding the different PPE barriers used when examining suspected COVID-19 cases, HCWs were reported to wear masks (medical or respirators) in 80% and gloves in 85% of health facilities of the full sample, as shown in Table 3. Eye or facial protection was the least likely recommended PPE to be worn (65%).

Table 3. PPE use: Barriers used when examining COVID-19 suspected patients and correct use of the equipment.

Country n Gowns Gloves Eye/facial protection Mask or respirator Wear the complete PPE set Always use PPE correctly
Bangladesh 291 52% 74% 55% 98% 35% 44%
Burkina Faso 159 91% 92% 94% 72% 67% 40%
Guinea 156 78% 92% 79% 71% 49% 37%
Nigeria 401 66% 87% 56% 74% 30% 48%
Sample 1007 68% 85% 65% 80% 41% 44%
Only for health facilities with a complete PPE set available
Bangladesh 103/291 70% 94% 86% 100% 66% 42%
Burkina Faso 120/159 93% 95% 96% 80% 76% 42%
Guinea 18/156 94% 94% 94% 94% 83% 39%
Nigeria 178/401 80% 87% 75% 73% 47% 58%
Sample 419/1007 82% 91% 84% 83% 61% 49%

We also found that HCWs did not use all the recommended PPE barriers when examining COVID-19 suspected or confirmed cases even when all items are available at the health facility. Restricting the sample to only health facilities with the complete PPE set available, we found that HCWs were wearing all the recommended barriers in only 61% of health facilities. The percentage was as low as 47% in Nigeria. HCWs were reported to wear protective gowns and gloves in 82% and 91% of health facilities when examining suspected or confirmed COVID-19 cases. Almost two health facilities out of 10 reported their HCWs skipped using masks or respirators in such cases, although the equipment was available. When asked about appropriate PPE use, health facility representatives reported their staff always used PPE correctly in less than half of the facilities with all pieces available, with minimal variation across countries.

Service adaptation and IPC measures when experiencing a severe shortage

We then explored whether facilities with PPE shortages implement the service adaptation measures recommended by the WHO guideline. Primarily, according to our definition of a severe shortage (i.e., neither mask nor gloves were available within the facility), 23% (229) of the health facilities were experiencing a severe shortage on the survey day as shown in Table 2.

IPC measures were generally more implemented than service delivery adaptations. We observed that 86% of the health facilities provided additional hand-washing stations, and 83% implemented social distancing, while 60% encouraged self-care and 58% provided all care in a single visit (Table 4).

Table 4. Service adaptation and IPC measures.

  Experiencing shortage Not experiencing shortage Full sample p-values  
  n % n % n % Countries in the sample
IPC measures
Regular surface cleaning 239 68% 556 85% 795 79% 0.0000 Bangladesh, Burkina Faso, Guatemala, Guinea, Liberia, Malawi, Nigeria
Hand washing stations 294 77% 779 90% 1073 86% 0.0000 Bangladesh, Burkina Faso, Guatemala, Guinea, Nigeria
Specific staff entrance 133 32% 635 56% 768 50% 0.0000 Bangladesh, Burkina Faso, Guatemala, Guinea, Liberia, Malawi, Nigeria
Screening patients for COVID-19 167 42% 718 69% 885 62% 0.0000 Bangladesh, Burkina Faso, Guatemala, Guinea, Malawi, Nigeria
Triage system for patients 131 33% 656 63% 787 55% 0.0000 Bangladesh, Burkina Faso, Guatemala, Guinea, Malawi, Nigeria
Social- distancing 139 77% 319 86% 458 83% 0.0070 Bangladesh, Liberia, Malawi, Nigeria
Service adaptation
Extend prescription 70 31% 331 46% 401 42% 0.0001 Bangladesh, Liberia, Malawi, Nigeria
Encourage self-care 148 65% 421 58% 569 60% 0.0574 Bangladesh, Liberia, Malawi, Nigeria
Provide all care in a single visit 136 60% 415 58% 551 58% 0.4863 Bangladesh, Liberia, Malawi, Nigeria
Switch to digital platform 49 25% 124 17% 173 27% 0.4087 Bangladesh, Nigeria

Implementing service adaptations can reduce the health risk during an in-person visit to the health facility when PPE is lacking. However, we did not observe a statistical difference in the implementation of such adaptations whether or not health facilities were experiencing a severe shortage. Thirty-one percent of the health facilities experiencing a severe shortage chose to extend prescription periods, 65% encourage self-care, 60% combine different services in a single visit, and 25% switch to digital platforms (Table 4). We observed similar magnitudes for implementing these measures in health centers not experiencing a severe shortage: 46% extended prescription, 58% encouraged self-care, 58% provided all care in a single visit, and 17% switched to digital platforms.

We found a significant positive correlation between PPE availability and adopting standard and COVID-19 specific IPC measures. Almost all (90%) health facilities with masks and gloves available had hand-washing stations inwards, compared to only 77% of health facilities experiencing a severe shortage. Health facilities not experiencing a severe PPE shortage were more likely to ensure social distancing was maintained within the facility by nine percentage points.

We also tested for different definitions of severe shortage, such as no mask available within the facility and having less than 3 of the necessary PPE pieces for a complete set. Changing the definition of PPE shortage did not affect the lack of correlation between shortages and service delivery adaptation. We ran this analysis differentiating by facility type and country, no significant relationship was found.

Discussion

We found that, after more than a year into the COVID-19 pandemic, most health facilities in LMICs were not fully equipped to respond to the COVID-19 pandemic. PPE availability was notably low in Guinea, Bangladesh, and Nigeria, where fewer than 70% of health facilities have all the recommended PPE. The shortage was particularly severe for respirators and masks. Less than half of all the health facilities sampled had medical masks available for all HCWs on the survey day. Hospitals had greater availability of the different PPE items in almost all settings. N95 or FFP2 respirators were only available to 15% of the health facilities in Guinea and 25% of the facilities in Bangladesh. These results were consistent with other studies on PPE availability in LMICs. For instance, the United Nations Office for Disaster Risk Reduction facility assessment in Kenya highlighted similar results. The complete PPE set was only available in 64% of the health facilities, and when items were available, stocks were usually too low to supply all HCWs [10]. We also observed substantial differences in PPE use across countries. This discrepancy can reflect many country-specific factors such as the existence of a domestic supplier, the strength of supply chains, health worker awareness/training, and/or the lack of global quality standards on the equipment [13]. Despite international donor, multilateral agency, government, and industry efforts to rapidly procure affordable and safe PPE during the early stages of the COVID-19 pandemic, many health facilities in LMICs had limited availability of PPE [14, 15]. While exacerbated by the pandemic, these shortages could have been impacted by pre-existing conditions.

Beyond the current pandemic context, PPE shortage is a chronic issue hindering the capacity to provide care in LMICs. Although we reported PPE shortages across contexts, availability might be better than in the pre-pandemic period in some settings. Gage, A., and Bauhoff, S. (2020) used the Service Provision Assessments (SPAs) of seven LMICS from 2015 to 2018 and found that face masks were available in less than a third of non-hospitals in Bangladesh, DRC, Nepal, and Tanzania [8]. The average availability of face masks in lower-level structures in our sample was close to 56%, and only in Guinea is availability lower than a third. SPA data from 2017 in Bangladesh also show that medical masks were only available in 28% of health facilities compared to 63% in our study [8]. The self-reported data on PPE availability before the pandemic in Burkina Faso and Guinea presented in S4 Table corroborates this idea. The increased availability compared to pre-pandemic data may reflect the effort to procure the equipment during the first months of the pandemic. However, the stagnation of the level of availability over rounds indicates persisting gaps in availability at many health facilities. Integrating global standards and availability targets for PPE into the health system’s preparedness evaluation may also incentivize countries to increase supply [13]. But, increasing supply alone may not be sufficient to protect health workers.

We also found that HCWs examining COVID-19 suspected cases were not systematically using the complete PPE set even when all barriers were available in their facilities. Many factors might explain why HCWs were not using PPE. PPE is constraining. Studies show that wearing PPE increases heat stress during practice and reduces HCWs’ performance [16]. HCWs may or may not wear PPE based on their risk perception. The occupational hazards may be perceived as less acute when patients do not exhibit physical symptoms [17]. In Malaysia, infection among HCWs was primarily driven by the inappropriate use of PPE when examining asymptomatic patients [18]. Incomplete knowledge, low level of training, and negative perception of equipment can also increase non-compliance with PPE protocols [19]. Additionally, facility-level interventions and policies to preserve PPE and encourage use may have an impact on the use of PPE.

Although there were country-specific guidelines and different levels of risk during a consultation, we did not find significant evidence of health facilities actively implementing measures to minimize the risk of infection in the event of a severe PPE shortage. Moreover, our results suggested health facilities with greater availability of PPE were more likely to implement IPC measures. Health facilities may have different priorities and resources available for IPC and service delivery adaptation [20]. The high risk of nosocomial infection in the event of a PPE shortage underscores the importance of service adaptation during an epidemic outbreak. Evidence from the 2013–2016 Ebola outbreak in West Africa suggested that the limited availability of PPE and lack of service provision adaptation made health facilities amplifiers of the spread of the disease [21]. As a result, many health facilities ended up closing due to HCW illnesses or to avoid infection at the health facility [22]. Supporting health facilities with implementation protocols to adapt services during shortages can help decrease the risk of nosocomial infection while maintaining service delivery [23].

This study has several limitations. First, we presented the general availability of PPE but did not provide insight on the adequacy of the stock level or the quality of the equipment at hand. Therefore, it cannot be assumed that facilities with supplies available would be able to ensure minimization of the risk of nosocomial infection. In addition, the timing of the phone survey may have also impacted our estimation depending on the delivery date of stocks and the prevalence of COVID-19 at the time of the survey. However, the small range of variations we observed over rounds suggests that levels of availability may have been somewhat stable over time. In addition, the country samples were not fully representative in all settings. The sampling strategy was usually to stratify by province and facility type to obtain nationally representative samples based on the master facility list provided by Ministries of Health which may not have been fully updated. These lists also compromised very few (or none) private health facilities, and we know little about what the situation in the private sector was in most countries.

Conclusion

PPE is the last line of defense for HCWs [22, 23]. In this study, we showed that the current level of availability of the different PPE pieces was insufficient to guarantee the safety of HCWs and patients during care in many primary-level health facilities. We also identified that HCWs were not using the complete set of PPE while examining COVID-19 suspected cases, even when all the relevant pieces were available. Finally, we found that facilities were more likely to make IPC-related adaptations than changes to service delivery.

While efforts were made to accelerate and enhance the production and dissemination of PPE globally, the availability of the equipment continued to require critical attention in many LMICs. Moreover, the availability of PPE should be accompanied by communication, supportive supervision, and attention to behavior change to increase their use. Finally, we believe closer attention to the implementation of IPC measures and more assistance to help health facilities identify and interpret PPE shortages are needed to establish an actionable plan for service provision adaptation.

Supporting information

S1 Table. Availability of PPE at the health facilities over rounds.

(DOCX)

S2 Table. Sampling strategy for each country.

(DOCX)

S3 Table. Response rate to the health facility phone survey for the round of the study.

(DOCX)

S4 Table. Availability of PPE before the COVID-19 pandemic in Burkina Faso and Guinea.

(DOCX)

Acknowledgments

We gratefully acknowledge the contributions of Alain-Desire Karibwami, Isidore Sieleunou, Munirat Ogunlayi, Julie Ruel Bergeron and other focal points from the GFF secretariat and GFF liaison officers Jean Christian Youmba, Marie Louise Mbula, Freddy Essimbi Onana Essomba, Mardieh Dennis, Pius MasaukoNakoma, Mamadou Namory Traoré and Umma Yaraduafor for facilitating data collection.

Data Availability

The data underlying this article were provided by and are property of the ministries of health of the seven countries participating in the analysis. The data will be shared on reasonable request with permission of the seven ministries from gffsecretariat@worldbank.org.

Funding Statement

The author(s) received no specific funding for this work.

References

Decision Letter 0

Allen Prabhaker Ugargol

28 Mar 2023

PONE-D-22-26371Availability and use of personal protective equipment in low- and middle-income countries during the COVID-19 pandemicPLOS ONE

Dear Dr. drouard,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 12 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Allen Prabhaker Ugargol

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

4. Please include a caption for figure 1.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Dear Authors,

The reviewers have provided their suggestions for improving the manuscript and the following observations are in order. We look forward to your revision as per these comments and suggestions.

1. The English used is in the present tense, while grammatically all manuscripts must be in the past tense, particuarly when it is a retrospective analysis

2. This is a survey which does not state how many times a telephone call or a contact was made and how many times was the response in the affirmative or negative

3. What were the criteria used for choosing the countries used in the survey For instance, Only Bangladesh features from SE Asia. The authors must define what were the criteria used for the same

4. The results are not adequate or complete to draw a proper conclusion from this study. The authors have stated that availability of the PPE doesnot gauarantee usage of PPE by the health care facility, a conclusion which is not adequately supported by the results of the study

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Good descriptive write up on inadequacy of PPE during pandemic. Gives readers a better understanding of situation in the low- and middle- income countries. It adds to literature database on PPE supplies.

Reviewer #2: The following observations are in order :

1. The English used is in the present tense, while grammatically all manuscripts must be in the past tense, particuarly when it is a retrospective analysis

2. This is a survey which does not state how many times a telephone call or a contact was made and how many times was the response in the affirmative or negative

3. What were the criteria used for choosing the countries used in the survey For instance, Only Bangladesh features from SE Asia. The authors must define what were the criteria used for the same

4. The results are not adequate or complete to draw a proper conclusion from this study. The authors have stated that availability of the PPE doesnot gauarantee usage of PPE by the health care facility, a conclusion which is not adequately supported by the results of the study

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Moi Lin Ling

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Jul 17;18(7):e0288465. doi: 10.1371/journal.pone.0288465.r002

Author response to Decision Letter 0


24 May 2023

To the editorial board of PLOS ONE,

Thank you for the invitation to respond to your and the reviewers’ comments and revise our manuscript. The comments were very helpful in improving the writing and better presenting our methodology and communicate our findings.

We are excited to submit a revised and improved manuscript for your review. Please find below a point-by-point response to the review comments. For easier reference, the received comments are boldfaced.

Sincerely,

Salomé Drouard

Editor’s comments

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at.

Response: Thank you. We have revised the manuscript according to the PLOS ONE’s guidelines.

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

Response: Thank you for the clarification, we added the following paragraph in the method section.

In the data collection paragraph: “Survey respondents generally included facility officer in-charges, but in some cases other respondents, like facility administrators, were better suited to answer modules within the survey.

In the ethical approval paragraph: “Survey participation was voluntary and verbal consent was received from all respondents.”

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Response: We added the following paragraph in the ethical approval paragraph of the method section.

“The study was requested, reviewed, and approved by a director-level official in each Ministry of Health and was exempted from human subjects research as public health practice in every country except Burkina Faso. In Burkina Faso, ethical approval was received from the ethics committee of the local author’s institute.”

4. Please include a caption for figure 1.

Response: Thank you. The caption was added to the main text with a legend.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Response: The captions were added, and the supporting information file updated according to the guidelines.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response: Thank you for your careful review and we apologize for this discrepancy due to an error in importing the bibliography from Mendeley. The following references were added in this order.

1. Cancedda C, Davis SM, DIerberg KL, Lascher J, Kelly JD, Barrie MB, et al. Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone. J Infect Dis. 2016;214: S153–S163. doi:10.1093/INFDIS/JIW345

2. Reddy SC, Valderrama AL, Kuhar DT. Improving the Use of Personal Protective Equipment: Applying Lessons Learned. Clinical Infectious Diseases. 2019;69: S165–S170. doi:10.1093/CID/CIZ619

3. Keep health workers safe to keep patients safe: WHO. [cited 28 Nov 2021]. Available: https://www.who.int/news/item/17-09-2020-keep-health-workers-safe-to-keep-patients-safe-who

4. Second round of the national pulse survey on continuity of essential health services during the COVID-19 pandemic. [cited 28 Nov 2021]. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS-continuity-survey-2021.1

5. Kazungu J, Munge K, Werner K, Risko N, Vecino-Ortiz AI, Were V. Examining the cost-effectiveness of personal protective equipment for formal healthcare workers in Kenya during the COVID-19 pandemic. BMC Health Serv Res. 2021;21: 1–7. doi:10.1186/S12913-021-07015-W/FIGURES/5

Reviewer 1’s comments

1. The English used is in the present tense, while grammatically all manuscripts must be in the past tense, particuarly when it is a retrospective analysis.

Response: Thank you for pointing this out. The manuscript was re-written in past tense.

2. This is a survey which does not state how many times a telephone call or a contact was made and how many times was the response in the affirmative or negative.

Response: Thank you for this comment. We added the following extract to the data collection paragraph in the method section and the following table to the supporting information:

Three attempts were made to reach each facility, and interview times were scheduled in advance to minimize burden on the respondents. In case of non-response, a replacement facility of the same facility level in the same province was randomly selected from the list of eligible health facilities when possible. More details on the response rate are available in S3 Table in the appendix. All the health facility representatives we managed to reach accepted to take part in the survey.

S3 Table. Response rate to the health facility phone survey for the round of the study

Country Round # of health facilities selected # of health facilities interviewed # of health facilities who cannot be reached or replaced Response rate

Bangladesh Jul-21 300 291 9 98%

Burkina Faso Aug-21 159 159 0 100%

Guatemala Jun-21 255 239 16 94%

Guinea Jul-21 160 156 4 98%

Liberia Jul-21 122 116 6 97%

Malawi Jun-21 204 192 12 94%

Nigeria May-21 421 401 20 95%

3. What were the criteria used for choosing the countries used in the survey For instance, Only Bangladesh features from SE Asia. The authors must define what were the criteria used for the same

Response: This study was part of a broader initiative supported by the Global Financing Facility for Women, Children, and Adolescents (GFF) to help member countries to monitor the effect of the COVID-19 pandemic on essential health services. All GFF member countries were offered to participate in the survey. The countries covered in this article were the countries for which at least one round of data was collected by August 2021.

We added the following extract to the overview and sample selection paragraph in the method section to document that point:

“In this context, implementation of facility phone surveys was offered to all partner countries. The seven countries covered by this study are the ones that opted to implement the phone survey and for which at least one round of data was completed by August 2021.”

4. The results are not adequate or complete to draw a proper conclusion from this study. The authors have stated that availability of the PPE does not guarantee usage of PPE by the health care facility, a conclusion which is not adequately supported by the results of the study.

Response: As we highlight in our paper, the availability of all the PPE barriers at the health facility does not guarantee that HCWs will wear all the recommended items when examining patients suspected to be infected with COVID-19. However, while not sufficient, the availability of all barrier PPE is necessary to comply with infection prevention control protocols.

We believe that our paper makes that point by stressing that, when restricting the sample to health facilities with all PPE barriers available, only 61% of the respondents declared their HCWs were wearing the complete PPE set when examining potential COVID-19 cases.

The results of our study imply that there is not only an urgent need to improve the availability of PPE barriers, as emphasized in the first part the article, but there is also a need for additional interventions to ensure HCWs appropriately use the barriers when they are available.

To make this point clearer we rephrase the following sentences in the result and discussion sections.

Rephrased sentences the result section:

“We also found that HCWs did not use all the recommended PPE barriers when examining COVID-19 suspected or confirmed cases even when all items are available at the health facility. Restricting the sample to only health facilities with the complete PPE set available, we found that HCWs were wearing all the recommended barriers in only 61% of health facilities.”

Rephrased sentence the discussion section:

“We also found that HCWs examining COVID-19 suspected cases were not systematically using the complete PPE set even when all barriers were available in their facilities.”

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Allen Prabhaker Ugargol

28 Jun 2023

Availability and use of personal protective equipment in low- and middle-income countries during the COVID-19 pandemic

PONE-D-22-26371R1

Dear Dr. Drouard,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Allen Prabhaker Ugargol

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Allen Prabhaker Ugargol

7 Jul 2023

PONE-D-22-26371R1

Availability and use of personal protective equipment in low- and middle-income countries during the COVID-19 pandemic

Dear Dr. Drouard:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Allen Prabhaker Ugargol

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Availability of PPE at the health facilities over rounds.

    (DOCX)

    S2 Table. Sampling strategy for each country.

    (DOCX)

    S3 Table. Response rate to the health facility phone survey for the round of the study.

    (DOCX)

    S4 Table. Availability of PPE before the COVID-19 pandemic in Burkina Faso and Guinea.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The data underlying this article were provided by and are property of the ministries of health of the seven countries participating in the analysis. The data will be shared on reasonable request with permission of the seven ministries from gffsecretariat@worldbank.org.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES